Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Brussels - Delayed Quote • EUR Nyxoah SA (NYXH.BR) Follow Add holdings 5.46 +0.06 +(1.11%) At close: May 2 at 5:35:09 PM GMT+2 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for NYXH.BR 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: NYXH.BR View More All News Press Releases SEC Filings Conditional Issuance of Shares Nyxoah Provides Update on FDA Approvable Letter for Genio System FDA Issues Nyxoah an Approvable Letter for its Genio® System Nyxoah SA (NYXH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic US ... Nyxoah SA (NYXH) Reports Q4 Loss, Lags Revenue Estimates Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025 Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East Hims & Hers Health (HIMS) Surges 27.7%: Is This an Indication of Further Gains? Publication relating to transparency notifications